Sign in

Filings

Finds words inside filing documents. Searching Serina Therapeutics, Inc.'s filings · 53 documents indexed.

4 documents · 26 matches

  1. SER Serina Therapeutics, Inc. 10-K 2026-03-25

    Item 1A. Risk Factors

    material weaknesses identified by our management in our internal control over financial reporting. A material weakness is a deficiency or combination
    8 matches in this document
  2. SER Serina Therapeutics, Inc. 10-Q 2025-11-13

    Item 4. Controls and Procedures

    material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable
    6 matches in this document
  3. SER Serina Therapeutics, Inc. 10-Q 2025-08-11

    Item 4. Controls and Procedures

    material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable
    6 matches in this document
  4. SER Serina Therapeutics, Inc. 10-Q 2025-05-08

    Item 4. Controls and Procedures

    material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable
    6 matches in this document

Page 1 of 1 · 4 documents